Consensus guidelines for the management of atopic dermatitis: An Asia-Pacific perspective

Journal of Dermatology

Volumn 40, Issue 3, 2013, Pages 160-171

  Rubel, Diana ^a   Thirumoorthy, Thiru ^b   Soebaryo, Retno W ^c   Weng, Steven C K ^d   Gabriel, Teresita M ^e   Villafuerte, Lillian L ^f   Chu, Chia Yu ^g   Dhar, Sandipan ^h   Parikh, Deepak ⁱ   Wong, Li Chuen ^j   Lo, Kuen Kong ^k  

^a CANBERRA HOSPITAL   (Australia)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c UNIVERSITY OF INDONESIA   (Indonesia)

^d Pantai Hospital   (Malaysia)

^e RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^f Jose R Reyes Memorial Medical Center   (Philippines)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h INSTITUTE OF CHILD HEALTH   (India)

ⁱ B J WADIA HOSPITAL FOR CHILDREN   (India)

^j CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^k UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Asia Pacific; atopic dermatitis; guidelines; topical calcineurin inhibitor; topical corticosteroid

Indexed keywords

AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE VALERATE; CHLORPHENIRAMINE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CLOXACILLIN; CORTICOSTEROID; CYCLOSPORIN; DESONIDE; DIFLUCORTOLONE VALERATE; EMOLLIENT AGENT; ERYTHROMYCIN; FLUTICASONE PROPIONATE; HALCINONIDE; HERBACEOUS AGENT; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE VALERATE; LORATADINE; METHOTREXATE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; PROBIOTIC AGENT; PSORALEN; TACROLIMUS; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG;

ACNE; ADRENAL SUPPRESSION; ANTIBIOTIC THERAPY; ARTICLE; ATOPIC DERMATITIS; BANDAGE; CHINESE HERB; CONSENSUS; CORTICOSTEROID THERAPY; CULTURAL ANTHROPOLOGY; DISEASE SEVERITY; DRUG EFFICACY; GENE MUTATION; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MOISTURE; NAUSEA; PARESTHESIA; PATIENT EDUCATION; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRACTICE GUIDELINE; PUVA; ROSACEA; SIDE EFFECT; SKIN ATROPHY; SKIN MANIFESTATION; STRIA; TELANGIECTASIA; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-INFECTIVE AGENTS; BANDAGES; CALCINEURIN; COMPLEMENTARY THERAPIES; DERMATITIS, ATOPIC; EMOLLIENTS; HISTAMINE ANTAGONISTS; HUMANS; PHOTOTHERAPY;

EID: 84874473867     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12065     Document Type: Article

References (74)

1. Dhar S, Kanwar AJ,. Grading of severity of atopic dermatitis in North Indian children. Indian J Dermatol 1995; 40: 67-72.
2. Chan YC, Tay YK, Sugito TL, et al,. A study on the knowledge, attitudes and practices of Southeast Asian dermatologists in the management of atopic dermatitis. Ann Acad Med Singapore 2006; 35: 794-803.
3. National Institute for Health and Clinical Excellence. Atopic eczema in children: Management of atopic eczema in children from birth up to the age of 12 years. Clinical Guideline, December 2007.
4. Saeki H, Furue M, Furukawa F, et al,. Guidelines for management of atopic dermatitis. J Dermatol 2009; 36: 563-577.
5. Australian Therapeutic Guidelines: Dermatology, version 3, 2009.
6. Katayama I, Kohno Y, Akiyama K, et al,. Japanese guideline for atopic dermatitis. Allergol Int 2011; 60: 205-220.
7. Lee SI, Kim J, Han Y, Ahn K,. A proposal: Atopic Dermatitis Organizer (ADO) guideline for children. Asia Pac Allergy 2011; 1: 53-63.
8. Adkis CA, Akdis M, Bieber T, et al,. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Alllergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 152-169.
9. Baron SE, Cohen SN, Archer CB, British Association of Dermatologists and Royal College of General Practitioners. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol 2012; 37 (Suppl 1): 7-12.
10. Ring J, Alomar A, Bieber T, Deleuran M, et al,. Guidelines for the treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26: 1045-1060.
11. Osawa R, Akiyama M, Shimizu H,. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011; 60: 1-9.
12. Chen H, Common JE, Haines RL, et al,. Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singapore Chinese and European populations. Br J Dermatol 2011; 165: 106-114.
13. Nomura T, Sandilands AM, Akiyama M, et al,. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007; 119: 434-440.
14. Shams K, Grindlay DJ, Williams HC,. What's new in atopic eczema? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol 2011; 36: 573-578.
15. Belloni G, Pinelli S, Veraldi S,. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol 2005; 15: 31-36.
16. Kircik LH, Del Rosso JQ,. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol 2011; 4: 25-31.
17. Lucky AW, Leach AD, Laskarzewski P, Wenck H,. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321-324.
18. Hanifin J, Gupta AK, Rajagopalan R,. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002; 147: 528-537.
19. Berth-Jones J, Damstra RJ, Golsch S, et al,. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326: 1367.
20. Grimalt R, Mengeaud V, Cambazard F,; The Study Investigator's Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214: 61-67.
21. Buys LM,. Treatment options for atopic dermatitis. Am Fam Physician 2007; 75: 523-528.
22. Vernon HJ, Lane AT, Weston W,. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991; 24: 603-607.
23. Rafanelli A, Rafanelli S, Stanganelli I, Marchesi E,. Mometasone furoate in the treatment of atopic dermatitis in children. J Eur Acad Dermatol Venereol 1993; 2: 225-230.
24. Faergemann J, Christensen O, Sjövall P, et al,. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2000; 14: 393-396.
25. Hong E, Smith S, Fischer G,. Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients. Pediatr Dermatol 2011; 28: 393-396.
26. Long CC, Finlay AY,. The finger-tip unit-a new practical measure. Clin Exp Dermatol 1991; 16: 444-447.
27. Nilsson EJ, Henning CG, Magnusson J,. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29-34.
28. Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P,. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131: 536-540.
29. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ,. Adverse effects of topical glucorticosteroids. J Am Acad Dermatol 2006; 54: 1-15.
30. Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ,. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol 1999; 140: 1114-1121.
31. Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B,. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol 2003; 49: 198-205.
32. Gollnick H, Kaufmann R, Stough D, et al,. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Br J Dermatol 2008; 158: 1083-1093.
33. Wollenberg A, Reitamo S, Girolomoni G, et al,. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008; 63: 742-750.
34. Dhar S, Banerjee R,. Topical tacrolimus in atopic dermatitis: a placebo controlled study with 15 children. Indian J Dermatol 2004; 49: 22-24.
35. ClinicalTrials.gov [Internet]. A pediatric longitudinal evaluation to assess the long-term safety of Protopic for the treatment of atopic dermatitis (APPLES). [updated 2012 June 28; cited 2012 Jul 5]. Available from: http://clinicaltrials.gov/ct2/show/NCT00475605.
36. Ring J, Möhrenschlager M, Henkel V,. The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy. Drug Saf 2008; 31: 185-198.
37. Thaci D, Salgo R,. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. Clin Dermatol 2010; 28: 52-56.
38. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC,. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005; 330: 516.
39. Hindley D, Galloway G, Murray J, Gardener L,. A randomized study of "wet wraps" versus conventional treatment for atopic eczema. Arch Dis Child 2006; 91: 164-168.
40. Hoare C, Li Wan Po A, Williams H,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4 (37): 1-191.
41. Goh CL, Wong JS, Giam YC,. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol 1997; 36: 653-657.
42. Dhar S, Kanwar AJ, Kaur S, Sharma P, Ganguly NK,. Role of Bacterial Flora in the pathogenesis and management of atopic dermatitis. Indian J Med Res 1992; 95: 234-238.
43. Loo WJ,. Irritant dermatitis due to prolonged contact with Oilatum Plus. Br J Dermatol 2003; 148: 171-172.
44. Saw NK, Hindmarsh JR,. Acute irritant reaction to an antiseptic bath emollient. Postgrad Med J 2005; 81: 131-132.
45. Hann S, Hughes TM, Stone NM,. Flexural allergic contact dermatitis to benzalkonium chloride in antiseptic bath oil. Br J Dermatol 2007; 157: 795-798.
46. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS,. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123: e808-e814.
47. La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA,. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy 1994; 73: 117-122.
48. Diepgen TL,; Early Treatment of the Atopic Child Study Group. Long-term treatment with cetirizine in infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002; 13: 278-286.
49. Chunharas A, Wisuthsarewong W, Wananukul S, Viravan S,. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream. J Med Assoc Thai 2002; 85: 482-487.
50. Munday J, Bloomfield R, Goldman M, et al,. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology 2002; 205: 40-45.
51. Grundmann SA, Beissert S,. Modern aspects of phototherapy for atopic dermatitis. J Allergy (Cairo) 2012; 2012: 121797.
52. Meduri NB, Vandergriff T, Rasmusssen H, Jacobe H,. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007; 23: 106-112.
53. Schmitt J, Schmitt N, Meurer M,. Cyclosporin in the treatment of patients with atopic eczema-a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2007; 21: 606-619.
54. Neuber K, Schwartz I, Itschert G, Dieck AT,. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol 2000; 143: 385-391.
55. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM,. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol 2001; 137: 870-873.
56. Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI,. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128: 353-359.
57. Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC,. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children with young adults. J Dermatolog Treat 2009; 20: 141-145.
58. Johnston GA, Bilbao RM, Graham-Brown RA,. The use of complementary medicine in children with atopic dermatitis in secondary care in Leicester. Br J Dermatol 2003; 149: 566-571.
59. Weston S, Halbert A, Richmond P, Prescott SL,. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; 90: 892-897.
60. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S,. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-1610.
61. Folster-Holst R, Muller F, Schnopp N, et al,. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006; 155: 1256-1261.
62. Kopp M, Hennemuth I, Heinzmann A, Urbanek R,. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121: e850-e856.
63. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E,. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076-1079.
64. Liu HN, Jay SK, Wong CK,. Chinese herbs and atopic dermatitis. Lancet 1993; 342: 1175-1176.
65. Fung AY, Look PC, Chong LY, But PP, Wong E,. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999; 38: 387-392.
66. Zhang W, Leonard T, Bath-Hextall F, et al,. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 2005; 18 (2): CD002291.
67. Hon KLE, Leung TF, Ng PC, et al,. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007; 157: 357-363.
68. Perharic L, Shaw D, Leon C, De Smet PA, Murray VS,. Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Vet Hum Toxicol 1995; 37: 562-566.
69. Ferguson JE, Chalmers RJG, Rowlands DJ,. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol 1997; 136: 592-593.
70. Kupfer J, Gieler U, Diepgen TL, et al,. Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial. J Psychomsom Res 2010; 68: 353-358.
71. Staab D, Diepgen TL, Fartasch M, et al,. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006; 332: 933-938.
72. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keophane SG,. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003; 149: 582-589.
73. Dhar S, Banerjee R, Dutta AK, Gupta AB,. Comparison between the severity of atopic dermatitis in Indian Children born and brought up in UK and USA and that of Indian children born and brought up in India. Indian J Dermatol 2003; 48: 200-202.
74. Gutman AB, Kligman AM, Sciacca J, James WD,. Soak and smear: a standard technique revisited. Arch Dermatol 2005; 141: 1556-1559.